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Severe sepsis is a medical emergency affecting up to 18 million individuals world wide, with an annual incidence of
750,000 in North America alone. Mortality ranges between 28-50% of those individuals stricken by severe sepsis.
Sepsis is a time critical illness, requiring early identification and prompt intervention in order to improve outcomes.
This observation has led to increased awareness and education in the field of Emergency Medicine; it has also led
to the implementation of critical interventions early in the course of patient management, specifically Early-Goal
Directed Therapy, and rapid administration of appropriate antimicrobials. This review begins with a brief summary
of the pathophysiology of sepsis, and then addresses the fundamental clinical aspects of ED identification and
resuscitation of the septic patient.
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Severe sepsis and septic shock are medical emergencies
which affect 18 million individuals per year world wide.
[1,2] This rate may actually represent an underestima-
tion on a global assessment, as some developing coun-
tries lack the advanced microbiology services necessary
to quantify the extent of devastation secondary to infec-
tion. In North America 750,000 individuals with severe
sepsis are hospitalized annually, and approximately
215,000 of those patient encounters result in death. [2]
Internationally, 1400 individuals die each day with the
care of septic patients costing European countries 7.6
billion euros annually. [2,3] On average, $16.7 billion US
dollars are spent to care for the severely septic patient
each year, with costs projected to rise by 1.5% per year.
[2] Specifically in US emergency departments (EDs), sus-
pected severe sepsis accounts for approximately 500,000
ED visits annually [4] and investigators have determined
that in patients with septic shock, the rate of mortality* Correspondence: david.gaieski@uphs.upenn.edu
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reproduction in any medium, provided the orincreases by 7.6% for each hour that effective antimicro-
bials are delayed. [5] Therefore care of the severely sep-
tic patient is of great interest to the emergency physician
and other care providers who are responsible for the ini-
tial management of this patient population.
Optimization of ED management of the septic patient
is a priority, as North American studies have shown that
two-thirds of septic patients enter the health system via
the ED, but also due to the acuity of illness at initial
presentation and the potential to alter patient outcome
with emergent interventions. Historically, invasive man-
agement and aggressive resuscitation of the septic pa-
tient occurred in the intensive care unit (ICU); however,
with further investigation, sepsis is now recognized as an
overwhelmingly time critical disease, requiring early ini-
tiation of care. In 2001, Rivers et al. published a land-
mark paper “Early goal-directed therapy in the treatment
of severe sepsis and septic shock,” describing a trial in
which 263 patients were randomized to either standard
care or early goal-directed therapy (EGDT), an aggres-
sive algorithmic approach to resuscitation initiated at
the earliest stage of critical infection. [6] By applying
EGDT, the authors realized a 16% absolute reduction
in mortality. [6] This randomized control trial laid
the foundation for significant advances in the care ofl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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emergency care provider in identification of the disease
and initiation of treatment. Additionally, hospital over-
crowding has become a public health dilemma in many
countries and optimizing sepsis care within the ED has
become a high priority as patients wait ever longer for
ICU and ward beds. [4] In a recent Canadian study,
Green and McIntyre determined that critically ill
patients awaiting ICU admission had a median length of
stay of 4.9 hours. [7].
In 1999 the American College of Critical Care Medicine
and the Society for Critical Care Medicine issued a “Prac-
tice parameter for hemodynamic support of sepsis in adult
patients in sepsis” where experts made recommendations
on fluid resuscitation, vasopressor therapy, inotropic ther-
apy and hemodynamic endpoints that should be employed
in the care of septic patients. [8] Shortly afterwards, The
Surviving Sepsis Campaign (SSC), a consensus group of
55 international experts convened and published a group
of guidelines for the care of the septic patient. The first
SSC Guidelines were published in 2004; they were subse-
quently revised in 2008. The goals of the SSC were to
present uniform definitions of severe sepsis and septic
shock as well as to issue comprehensive, evidence-based
guidelines on the optimal care of the septic patient. These
guidelines were divided into an initial six-hour resuscitation
bundle and a subsequent 6–24 hour bundle for longer-
term management of the critically ill septic patient. [9,10]
Despite published guidelines, the use of these therapies for
the care of the septic patient remains low. [11,12] Studies
have shown that implementation of bundled care as recom-
mended by SSC may decrease mortality; however, only
approximately 30% of patients received bundled care. [13].
Pathophysiology
Sepsis is a disease process that is initiated by introduc-
tion of pathogens into the human host. Host cell recog-
nition of these pathogens as “foreign” results in the
release of the cytosolic nuclear factor, NF-κβ, which
binds to the nucleus and triggers the production of vari-
ous cytokines within the inflammatory cascade. [14] In
addition, polymorphonuclear leukocytes become acti-
vated and express adhesion molecules resulting in mar-
gination or mobilization of these white blood cells to
the source of infection. The sum of these processes is a
pro-inflammatory response, which is modulated by an
anti-inflammatory response mounted by the same host
organism. The pro-inflammatory response, mediated by
inflammatory markers including TNF-α, interferon γ,
interleukin (IL)-1, IL-2, and IL-6, triggers the release of
additional mediators, which results in characteristic
clinical findings of inflammation including fever, tachy-
cardia and tachypnea. However, investigators have found
that as sepsis persists there is a shift toward an anti-inflammatory response mediated by IL-4 and IL-10. It is
theorized that overwhelming sepsis occurs due to a dys-
regulation in the complex balance between pro-
inflammatory mediators or the systemic inflammatory
response (SIRS), and anti-inflammatory mediators, or
the compensatory anti-inflammatory response (CARS),
resulting in processes that directly damage endothelial,
cardiovascular, hemodynamic and coagulation mechan-
isms. [15] The end result of these pro- and anti-
inflammatory responses is cardiovascular compromise,
apoptosis (cell death), irreversible organ dysfunction,
suppression of the immune response, and death.
Clinical features
Sepsis is defined as the presence of a source of infection
and evidence of a systemic inflammatory response to
that infection as measured by the existence of two or
more SIRS criteria. Clinical features of sepsis include
three of the SIRS criteria; a temperature greater than
100.4°F or less than 96.8°F (>38.0°C or< 36.0°C); tachy-
cardia, a heart rate greater than 90 beats/minute; and
tachypnea, a respiratory rate greater than 20 breaths/
minute; the basic laboratory finding of sepsis is a white
blood cell count greater than 12 thousand/mm3 or less
than 4 thousand/mm3 or greater than 10% immature
cells and constitutes the fourth SIRS criteria.
The above scenario, coupled with signs of end organ
dysfunction due to microvascular compromise and poor
perfusion, defines severe sepsis. De Backer et al. utilized
an orthogonal polarization spectral imaging technique to
establish that sublingual microcirculation in septic
patients is impaired in comparison to healthy volunteers
and non-septic critically ill patients. Additionally, the
proportion of perfused small vessels was directly corre-
lated with survival, where survivors had a higher rate of
perfusion. [16] Poor perfusion of the brain may result in
altered mental status; poor renal perfusion may lead to
oliguria or anuria; poor cardiac perfusion may result in
myocardial depression, decreased cardiac output, and
hypotension or signs of heart failure; skin may be
mottled; lung dysfunction may result in acute lung injury
or acute respiratory distress syndrome.
Septic shock is a subset of severe sepsis characterized
by hypotension unresponsive to fluid resuscitation.
Sepsis-induced hypotension is defined as a systolic blood
pressure (SBP) less than 90 mmHg or a reduction of
greater than 40 mmHg from baseline. [3] Despite the
significant end organ dysfunction found in severe sepsis,
the actual mechanism for why patients die from sepsis is
not clearly known.
Early Identification and diagnostic criteria
The initial management of sepsis requires correct identi-
fication of septic patients by acute care providers.
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classify patients by severity of illness, with an initial set
of vital signs, chief complaint, and focused physical
exam. During this first encounter with the health care
delivery system, much information can be gleaned with
respect to the presence or potential for evolution of se-
vere sepsis and septic shock. It is critical to recognize
that not all individuals who have SIRS criteria are septic,
nor is it accurate to assume that patients without SIRS
criteria are not septic. As Bone et al. discussed in the
ACCP/SCCM consensus statement in 1992 there is
much overlap in these initial hemodynamic alterations
with disease entities such as burns, trauma, and pancrea-
titis and practitioners must render further clinical judg-
ment in order to accurately diagnose the septic patient
(Figure 1). [3] Comstedt et al. evaluated acutely ill indivi-
duals admitted to a Danish hospital and found that 35%
of this cohort met SIRS criteria on admission and had
an increased likelihood of infection (relative risk, 2.2)
within two days of admission versus the non-SIRS co-
hort. The SIRS cohort was also found to have a 6.9 times
greater risk of 28-day mortality than the non-SIRS co-
hort. [17] Similarly, in 2006 Shapiro et al. found that in
3102 adult patients with suspected infection, the pres-
ence of SIRS criteria alone had no prognostic value, but
that identifying organ dysfunction yielded relevant prog-
nostic information. [18] In total, 34% of patients with se-
vere sepsis and 24% of patients with septic shock did not
meet SIRS criteria during their ED stay. Therefore, SIRS
criteria do not necessarily define the sepsis syndrome,
and first line emergency care practitioners should per-
form a thorough physical exam and incorporate the
results of additional studies in order to accurately define
this cohort of patients.Figure 1 The interrelationship between systemic inflammatory
response syndrome (SIRS), sepsis, and Infection. Used with the
permission of CHEST.License number2835980252893.Several mechanisms have been proposed to assist in
the identification of patients with sepsis. Recent atten-
tion has focused on the topic of biomarkers, with serum
lactate being the best studied. Whether a marker of poor
perfusion, leading to increased lactate production, or an
indicator of impaired clearance secondary to organ dys-
function, multiple studies have shown that elevation in
serum lactate is an effective marker for risk stratification
of severe sepsis patients in the ED. [19,20] In a recent
study by Mikkelsen et al., the investigators demonstrated
that elevations in serum lactate independent of clinically
relevant hypotension were associated with increased
mortality in patients who present to the ED with severe
sepsis. [21] Taken together, these studies suggest that
serum lactate may perform well as a screening test in
the medical decision-making process regarding early ED
management and disposition of the septic patient.
As early as 1964, Dr. Max Harry Weil proposed that
serum lactate measured during critical illness correlated
with adverse outcomes. Broder and Weil determined
that in a cohort of patients with mixed critical illness,
individuals with a lactate excess of at least 4 mmol/L
had a mortality rate of 87%. [22] This finding was fur-
ther validated by Aduen and colleagues in 1994 measur-
ing lactate levels (not lactate excess) [23] and was
subsequently used by Rivers et al. as an inclusion criter-
ion for patients screened for the original EGDT trial. [6].
More recently, investigators have begun to address ele-
vated serum lactate levels that are lower than the
4 mmol/L traditionally used to capture patients for pro-
tocolized resuscitation. The rationale behind this ap-
proach is to identify and treat severe sepsis patients
earlier in their clinical course to halt the inflammatory
cascade and reverse perfusion abnormalities before they
progress further. Shapiro et al. analyzed 1,280 medical
records of patients with sepsis who had a low lactate
level (0–2.5 mmol/L) vs. intermediate lactate level (2.5-
3.9 mmol/L) vs. high lactate (≥ 4.0 mmol/L) and deter-
mined that their mortality rates were 4.9%, 9.0% and
28.4% respectively. [20] Similarly, Mikkelsen et al. found
that hemodynamically stable individuals with a lactate
between 2.0-3.9 mmol/L had a mortality rate that was
twice that of those with a lactate less than 2.0 mmol/L.
[21] These recent findings are consistent with original
research demonstrating that a lactate ≥ 4.0 mmol/L is
concerning for end organ dysfunction and adverse out-
comes; in addition, they suggest that patients with an
intermediate lactate level are also at increased risk of ad-
verse outcome relative to those with a normal lactate
level.
Other techniques have been applied in order to deter-
mine illness severity of the septic patient in the ED. In
one study, investigators examined the utility of quantify-
ing the number of organ systems that were impaired as
Table 1 First hours of management in life-threatening
infections
Time Intervention
Triage •Screen for SIRS with vital signs
•Screen for source by history and physical exam
•Evaluate for organ dysfunction by assessing vital
signs and level of consciousness
Immediate •Assess ABCs
•Establish definitive airway
•Initiate NIPPVwhile preparing for intubation
unless patient is apneic
•Lung protective ventilator strategies




1st Hour •Send labs including lactate and blood cultures
•Establish source control via broad spectrum
antimicrobials and/or definitive management
•Check ABG to ensure adequate gas exchange
and avoid hyperoxia
•Check plateau pressure to avoid barotrauma
•Consider bedside ultrasound to assess cardiac




•SBP< 90 mmHg after 20-30 cc/kg bolus
•Lactate> 4 mmol/L
1st Two Hours •If EGDT eligible, place CVC in torso vein, assess
CVP, ScvO2•If persistent hypotension (MAP< 65
mmHg), place arterial line
Two Hours •Repeat lactate and calculate clearance
•Assess total volume input and urine output
Three Hours •Reassess input/output; assess resuscitation goals;
is patient still volume responsive?
•Repeat labs to assess for correction of organ
dysfunction
Four to Six Hours •Final disposition
•If resuscitation goals met, enter maintenance
phase
•If not met, reassess
•Consider corticosteroids for vasopressor
dependent hypotension
•Assess need for glucose control
Every 20-30 Minutes •Serial reassessment of response to resuscitation
SIRS = systemic inflammatory response syndrome; ABC=Airway, Breathing,
Circulation; IV = Intravenous; IVC = inferior vena cava; SBP= systolic blood
pressure; EGDT= early goal directed therapy; CVC= central venous catheter;
CVP = central venous pressure; MAP=mean arterial pressure;
NIPPV =Noninvasive Positive Pressure Ventilation.
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individuals who had been admitted from the ED with a
diagnosis of sepsis. From this chart review, they deter-
mined that the mortality rate increased with each add-
itional organ system that was impaired (increased
adjusted 1-year mortality hazard ratio by 82%). [18].
Another approach to early identification of high risk
ED patients with sepsis is to use illness severity scoring
systems. For example, Shapiro et al. reviewed 3000 pa-
tient encounters in order to create a 9-part ED-specific
scoring system titled the Mortality in Emergency Depart-
ment Sepsis (MEDS) score. This instrument stratifies
patients into mortality risk groups of very low, low,
moderate, high, and very high. Mortality rates in these
risk groups were 1.1%, 4.4%, 9.3%, 16% and 39% respect-
ively. The area under the receiver operating characteris-
tic (ROC) curve was 0.82 in the derivation set and 0.78
in the validation set. [24] Unfortunately, when Jones
et al. attempted to validate the MEDS score, they found
that it performed poorly within their cohort, with an
area under the ROC curve of 0.61 (95% CI 0.50-0.72).
[25].
Attempts have also been made to validate currently
employed ICU scoring systems in the ED setting to risk
stratify patients with possible sepsis. In the ICU setting,
the Sequential Organ Failure Assessment (SOFA) score
numerically quantifies organ impairment at 24-hour
intervals. The SOFA score is a validated objective score
that allows for assessment of the number of impaired
organs as well as the severity of impairment. Jones et al.
in 2009 enrolled 248 subjects with severe sepsis who
were being treated with a standardized resuscitation
protocol. The area under the ROC curve was 0.75 (95%
CI 0.68-0.83) for SOFA score at time 0 and 0.84 (95%CI
0.77-0.90) at time 72 hours after presentation. [26]
These findings show that the SOFA score demonstrates
good accuracy at predicting in-hospital mortality early in
the course of illness when screened in the ED.
ED management
The initial management of the ED patient follows a simple
and well-defined algorithm regardless of the etiology of
the patient’s current illness. The ABCs of resuscitation in-
struct practitioners to evaluate the airway and, when
required, establish a patent, definitive airway; evaluate for
adequacy of breathing; and rapidly assess circulatory sta-
tus. Emergency Department evaluation of critically ill
patients also includes rapid establishment of adequate
intravenous (IV) access (two 18 gauge or larger IVs at the
outset of resuscitation), surveillance laboratory work, initi-
ation of fluid bolus to reestablish preload if indicated, and
obtaining appropriate diagnostic studies (Table 1). With
special focus on the severe sepsis patient, initial manage-
ment should include blood and urine cultures, sourcecontrol where appropriate, and rapid administration of ap-
propriate antimicrobials. This is not to say that definitive
identification of the site of infection and causative
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physical examination generating an appropriate differen-
tial diagnosis of the infectious process is critical for deli-
vering appropriate antimicrobials, establishing source
control, and guiding hemodynamic resuscitation.
Resuscitation: hemodynamic monitoring and physiologic
optimization
Protocolized resuscitation of patients with severe sepsis
and septic shock has become a widely recommended
standard for patients with fluid refractory septic shock.
Given the long ED boarding times in healthcare systems
plagued by overcrowding, hemodynamic monitoring and
physiologic optimization have become a necessary prac-
tice in acute care settings, prior to transfer to an ICU.
Volume resuscitation (20-30 cc/kg of normal saline or
lactated ringer’s solution over 15–30 minutes) should be
initiated as soon as hypoperfusion is recognized regard-
less of patient location in the health care system. [9] In a
randomized, controlled trial published in the New Eng-
land Journal of Medicine in 2001, Rivers et al. demon-
strated the time-critical nature of severe sepsis and
septic shock, establishing the efficacy of a protocol for
ED resuscitation known as Early Goal-Directed Therapy
(EGDT). [6] The relevant hemodynamic end points for
resuscitation employed in an algorithmic fashion in the
EGDT arm of the trial were: a central venous pressure
(CVP) of 8 to 12 mmHg; a mean arterial pressure
(MAP) of 65 to 90 mmHg; and a central venous oxygen
saturation (Scv02) ≥ 70%. The standard therapy arm
employed the following goals: a CVP of 8 to 12 mmHg;
a MAP> 65 mmHg; and urine output≥ 0.5 mL/kg/hr.
The trial included 263 subjects randomized to the two
arms and found a 16% absolute reduction in in-hospital
mortality in the EGDT arm vs. the standard therapy
arm. [6] This mortality benefit remained at 28 and
60 days.
In 2005 Otero et al. published a review analyzing the
outcomes from 12 additional hospital EDs that had
implemented an EGDT protocol. [27] The overall de-
cline in mortality observed was from 44.8 ± 7.8% pre-
implementation to 24.5 ± 5.5% post-implementation.
These findings support the results of the initial rando-
mized controlled trial by Rivers et al. from 2001. In the
2008 SSC Guidelines, the EGDT resuscitation algorithm
was endorsed as a grade 1 C (strong recommendation,
low quality of evidence) recommendation. However, sev-
eral investigators have questioned the validity of the in-
dividual hemodynamic markers utilized in EGDT and
continue to search for other less invasive mechanisms
for assessing the progress and adequacy of resuscitation.
[10,28].
As early as 1999 the Society for Critical Care Medicine
issued a practice parameter for the management ofsevere sepsis in which one goal of early management
was to correct the “early hypovolemic, hypodynamic
phase of sepsis” with aggressive volume resuscitation. [8]
Criticism has arisen as to whether this aggressive volume
resuscitation could actually be harmful to patients with
severe sepsis. In 2011, Boyd et al. performed a retro-
spective review of patients with vasopressor-dependent
severe sepsis enrolled in the Vasopressin in Septic Shock
Trial (VASST) and found that patients with a mean CVP
of< 8 mmHg had the lowest rates of mortality followed
by patients maintained at the guideline parameter of
8–12 mmHg. Finally, they noted that patients with a
CVP> 12 mm Hg had the worst outcomes. [29] It is
important to note that this study investigated the first
four days of sepsis management, and that the earliest
measurements documented were 12 hours after initi-
ation of management, which may be a time frame that
extends out of the early hypovolemic, hypodynamic
phase of sepsis. This study actually questions the timing
of when aggressive volume resuscitation should be
decreased and not the role of aggressive fluid adminis-
tration in the early phase of sepsis management. To fur-
ther support this conclusion, Murphy et al. found that
patients with septic shock and acute lung injury who
underwent adequate initial fluid resuscitation and subse-
quent conservative late fluid management had better
outcomes then patients who had only one or neither of
these fluid management strategies. [30].
Central venous pressure is a controversial measure-
ment in critical care management. Healthy individuals
typically have CVP values ranging from 0 to 8 mmHg,
while intubated patients will have higher CVPs due to
the effects of positive pressure ventilation on intra-
thoracic pressure. Marik et al. reviewed 24 studies exam-
ining the accuracy of CVP measurement. [28] They
found that CVP is a very poor measurement of blood
volume or of volume responsiveness; however, the stud-
ies reviewed were exclusively ICU or operating room
studies and the patients enrolled may not be representa-
tive of severely septic ED patients at the most proximal
phase of critical illness. The previously mentioned study
by Boyd et al. found that the CVP measurements in the
early phase of resuscitation correlated modestly with
fluid balance at 12 hours but had no significant correl-
ation on days 1–4. [29] This suggests that CVP may be
most useful in the early, dynamic phase of severe sepsis
and septic shock. In addition to its use as a resuscitation
endpoint, Varpula and colleagues found that mean CVP
the first 48 hours after admission to the ICU is inde-
pendently associated with mortality in septic shock. [31]
Mean arterial pressure (MAP) is a macroscopic meas-
ure of global organ perfusion. It is the average pressure
in one cardiac cycle and can be calculated using the fol-
lowing formulas: (1/3 *SBP) + (2/3* DBP) or DBP + (1/3*
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stolic blood pressure; and PP is pulse pressure. Mean ar-
terial pressure, however, can be misleading when used as
an endpoint of resuscitation in isolation because it is dir-
ectly related to systemic vascular resistance (SVR) and
cardiac output (CO). In compensated shock, a patient
may have depressed CO masked by elevated SVR result-
ing in a normal or modestly elevated MAP. A MAP
of ≥ 60 mmHg is needed to maintain nutrient and oxy-
gen flow into tissue beds that may have altered autore-
gulation secondary to the sepsis syndrome or
concomitantly administered medications. Although sug-
gested MAP goals range from ≥ 60 to ≤ 90 mmHg [32,33]
there are limited data that suggest using a MAP
target ≥ 65 mmHg will result in increased cardiac output,
improved microvascular function, and decreased blood
lactate concentrations. [34].
Central venous oxygen saturation (ScvO2) is a meas-
urement of the amount of oxygen remaining in the ven-
ous circulation after oxygen for cellular metabolism has
been extracted systemically. In addition, abnormal ScvO2
values in patients who are hemodynamically stable can
serve as a warning sign of impending sudden cardiovas-
cular collapse6. It is measured via a central venous cath-
eter with the tip placed at the atriocaval junction, a
common procedure for the emergency medicine practi-
tioner. Typically, the catheter is placed under ultrasound
guidance in the right internal jugular vein. Other accept-
able locations are the left internal jugular and subclavian
veins. Values of ScvO2 can be obtained continuously via
a specialized oximetric catheter or at the clinician’s dis-
cretion by drawing a venous blood gas from the distal
port and measuring the oxygen saturation. The ScvO2 is
often compared to an until recently more familiar meas-
urement, the mixed venous oxygen saturation (SvO2)
measured via a pulmonary artery catheter (PAC), occa-
sionally placed by intensivists after the patient arrives in
the ICU. Because of the added risk of placing a PAC,
coupled with the infrequent use of this modality for
hemodynamic monitoring, the ScvO2 is often utilized
as a surrogate for the SvO2. Ladakis and colleagues
found that in 61 critically ill ICU patients, the SvO2
and ScvO2 showed statistically significant correlation
with an r-value of 0.945 (p< 0.03). [35] These findings
were confirmed more recently in work published by
Mozina and Podbregar who determined a Pearson’s cor-
relation of 0.659 (p = 0.001) for the relationship between
SvO2 and ScvO2. [36] These investigators did find that
in patients with severe left heart failure there maybe a
discrepancy in the correlation between these two mea-
surements. The rationale behind the EGDT endpoint of
an ScvO2 ≥ 70% is to ensure that oxygen delivery is suf-
ficient to meet the oxygen demands of cellular metabol-
ism at the tissue level. Investigators have also studiedthe clinical meaning of ScvO2 ≥ 90%, and whether this
could be representative of poor oxygen extraction due
to tissue deficits at the mitochondrial level. Pope and
colleagues investigated over 600 patients from four aca-
demic ED EGDT registries and found that initial
hyperoxia (defined as an ScvO2 ≥ 90%) was associated
with a higher mortality rate (31 %, 95 % CI 21-48 %)
when compared to initial normoxia, defined as an
ScvO2 between 70 and 90% (23%, 95% CI 19-28 %)) and
hypoxia, defined as an ScvO2 ≤70% (25%, 95% CI 20-
31 %). [37] When investigating the maximum ScvO2ob-
tained in the ED, both the hypoxia and hyperoxia
groups exhibited a higher mortality rate, 40% and 34%
respectively, vs. the normoxia group (21%). Further in-
vestigation is necessary to understand the cellular
mechanisms for why the mortality in the hyperoxia
group is similar to that in the hypoxia group and to de-
termine plausible clinical interventions to correct hyper-
oxia during resuscitation.
Because of barriers to initiating invasive monitoring in
many EDs, combined with the increased risk associated
with placement of central venous access, investigators
have continued to search for less invasive modalities for
assessing hemodynamic status and outcomes of resusci-
tation. One value that has been investigated to assess ad-
equacy of resuscitation is lactate clearance--examining
change in serial lactate values over time. Nguyen and
colleagues investigated the prognostic value of lactate
clearance after six hours of ED resuscitation in a single
center with an active EGDT program. Using a prospect-
ive observational convenience sample of severe sepsis
and septic shock patients with a mean initial lactate of
6.9 mmol/L, they determined that a lactate clearance
of ≥ 10% was associated with a significant reduction in
mortality when compared to patients whose lactate
clearance was< 10%. [38] Jones and colleagues
attempted to investigate the non-inferiority of lactate
clearance vs. ScvO2 monitoring as the final end-point of
resuscitation in patients with severe sepsis or septic
shock. [39] This study was a randomized controlled trial
where one arm consisted of patients who were resusci-
tated to similar CVP, MAP and ScvO2 goals as used in
the Rivers trial. The second arm targeted the same CVP
and MAP goals; however, the third resuscitation goal
was a lactate clearance of at least 10% when a repeat lac-
tate was drawn two or more hours after the initial lac-
tate was obtained. Researchers found that 23% of
patients in the ScvO2 group died during hospitalization
compared to 17% of patients in the lactate clearance
arm (not statistically significant). This study was only
designed as a non-inferiority trial; therefore, researchers
concluded that there was no difference between out-
comes in patients managed using lactate clearance vs.
those managed by normalization of ScvO2. It is
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tate clearance group was 3.9 mmol/L vs. 4.2 mmol/L in
the EGDT group while in Rivers et al’s trial the mean
lactate in the EGDT group was 7.7 ± 4.7 mmol/L. [6]
The difference in patient severity of illness is also
reflected in the overall in-hospital mortality rates in both
studies, 20% in Jones’s versus 38% in Rivers’ study, re-
spectively. Although lactate clearance is an important re-
suscitation parameter, many patients in shock never
generate abnormal lactate levels. [40] Furthermore, using
a percent clearance may not be as useful as trending the
absolute lactate level or normalization of the lactate
level. As with all resuscitation parameters, lactate clear-
ance is best used in conjunction with all other available
data.
Another non-invasive tool to gauge the adequacy of
resuscitation is measuring the decrease in inferior vena
cava diameter during one respiratory cycle with bedside
ultrasonography, known as the caval index. Nagdev and
colleagues investigated the utility of correlating caval
index with CVP as recorded by central venous
catheterization. [41] Seventy-three patients with mixed
critical illness were enrolled in this study and the
researchers found that the correlation between caval
index and CVP was −0.74 (95% CI −0.82 to −0.63). They
also determined that the ability for a caval index≥ 50%
to predict a CVP of< 8 mmHg had a sensitivity of
91% (95% CI 71%-99%) and a specificity of 94% (95%
CI 84%-99%). The utility of measuring caval index specif-
ically in septic patients still needs to be further validated.
Other limitations of ultrasound include inter-operator
variability and variations in patient body habitus, which
may alter the quality of images obtained.
Investigators have also examined the utility of imped-
ance cardiography (ICG) as a non-invasive mechanism
for measuring hemodynamic status in severe sepsis.
Napoli et al. investigated the ability of cardiac index
obtained in the ED using ICG monitoring to predict in-
hospital mortality for patients who meet diagnostic cri-
teria for EGDT. [42] The ICG device, a series of sensors
to transmit current and measure impedance, placed on
opposing sides of the neck and thorax, was used on 56
patients in this study. Investigators determined that the
mean cardiac index in non-survivors was 2.3 L/min m2
(95% CI 1.6-3.0) and for survivors was 3.2 L/min m2
(95% CI 2.9-3.5). In their study, a cardiac index< 2 L/
min m2 had a sensitivity of 43% (95% CI 18%-71%), a
specificity of 93% (95% CI 80%-95%), a positive likelihood
ratio of 5.9, and a negative likelihood ratio of 0.6 for pre-
dicting in-hospital mortality. This study indicates that
non-invasive ICG monitoring may have some utility in
predicting outcomes for patients undergoing EGDT,
however, its utility in real-time hemodynamic monitoring
needs to be further investigated.Near infrared-spectroscopy has recently been used for
non-invasive monitoring of tissue oxygen saturation
(StO2). Investigators theorized that this measurement
might correlate with ScVO2 measurements and could be
utilized as a non-invasive surrogate for venous oxygen
saturation. Napoli et al. investigated the relationship be-
tween these two measurements in 40 ED patients with
severe sepsis or septic shock and found that StO2 sys-
tematically overestimated at lower ScvO2 and underesti-
mated at higher ScvO2, with an overall fair correlation
between the two measurements. [43] They concluded
that the clinical use of StO2 in this patient population is
unsubstantiated.
Several other dynamic endpoints of resuscitation use
arterial waveform (including pulse pressure variability
and stroke volume variability) or pulse oximetry wave-
form analysis. While they all show promise, they are un-
reliable in patients who are not intubated, who are
intubated and being treated with low tidal volume venti-
lation, or who have cardiac dysrhythmias. Until further
information is known and validated, the algorithmic ap-
proach to EGDT using invasive hemodynamic monitor-
ing has proven success in the outcomes of patients with
severe sepsis and septic shock and is still utilized and
recommended by many in the emergency medicine
community.
Resuscitation: pharmacologic interventions
An additional factor within the algorithmic approach to
hemodynamic resuscitation of the septic patient is
pharmacologic intervention with vasopressors. Over the
past decades, both dopamine and norepinephrine have
been regarded as first line agents appropriate for the
management of septic shock. In 2010, in The New Eng-
land Journal of Medicine, De Backer and colleagues pub-
lished a multicenter randomized controlled trial where
patients with shock were assigned to receive either nor-
epinephrine or dopamine as their initial vasopressor.
[44] If patients were not responsive to titrated dosing of
either medication, open label use of a second vasopres-
sor was allowed. Investigators determined that there was
a trend towards an increase in mortality in patients
started on dopamine (52.5% vs. 48.5%, p = 0.10), and a
higher rate of open label norepinephrine use after the
initial dose of dopamine. In addition, investigators found
that dopamine had a worse side effect profile than nor-
epinephrine, with more arrhythmic events (24.1% vs.
12.4%, p< 0.001). Although no significant difference in
mortality outcomes was noted, this study raises signifi-
cant concerns regarding the safety of dopamine in the
care of shock patients who are vasopressor-dependent.
Vasopressin has been utilized as an adjuvant therapy in
the vasopressor-dependent septic shock patient. Prior
studies have established a relative vasopressin deficiency
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rized that vasopressin as low-dose hormone replacement
may restore vascular tone and blood pressure, allowing for
reduced doses of catecholamines. In a randomized double
blind trial, Russell et al. assigned 778 septic patients who
remained hypotensive despite norepinephrine therapy to
receive either additional norepinephrine or low dose vaso-
pressin. [45] Investigators found no difference in mortality
between the vasopressin arm and the norepinephrine arm,
and reported that there was no utility in adding vasopres-
sin to the treatment algorithm of septic shock patients re-
ceiving norepinephrine.
During the last decade, tight glycemic control became
one of the cornerstones of management of critically ill
ICU patients. This emphasis on glycemic control
stemmed from a 2001 study where Van den Berghe et al.
addressed the issue of tight glucose control in a cohort
of critically ill surgical patients. [46] The authors found
that tight glycemic control reduced ICU mortality from
8.0% to 4.6% (p = 0.005) when compared to prior prac-
tice where insulin was only administered if the serum
blood glucose was greater than 215 mg/dL. However,
concerns about complications of hypoglycemia remained
and investigators sought to address this question in a
meta-analysis. A study, conducted by Wiener et al. ana-
lyzed 34 randomized controlled trials pertaining to tight
glycemic control in the ICU. [47] They found that over-
all mortality rates did not differ between patients receiv-
ing tight glucose control vs. those who were cared for
under a standard protocol (21.6% vs. 23.3%; RR 0.93;
95% CI 0.85-1.03). These studies were all conducted on
patients being cared for in the ICU, and there are little
data to guide the ED practitioner regarding glucose con-
trol during the first hours of the management of patients
with life-threatening infections. It is reasonable for the
emergency medicine provider to aim for a serum glucose
of 8.3 mmol/l (150 mg/dl) and to treat any serum glu-
cose over 12 mmol/l (~215 mg/dl).
The utility of steroid administration in the treatment
of septic shock has been a significant topic of interest to
investigators and clinicians. Annane et al. administered
low dose hydrocortisone and fludrocortisone to patients
with septic shock [48] and determined that, in patients
with relative adrenal insufficiency, this regimen resulted
in lower mortality and fewer days of vasopressor-
dependency. These findings were utilized by practi-
tioners until 2008 when the CORTICUS trial was
published in The New England Journal of Medicine.
CORTICUS was a multicenter, randomized, double-
blind, placebo-controlled trial, in which patients were
randomized to receive either 50 mg of hydrocortisone
every 6 hours for five days or placebo, followed by a
6-day taper of either steroid or placebo. [49] The primary
outcome was 28-day all cause mortality in patients whodid not respond to a corticotropin stimulation test.
Researchers found that there was no difference in mor-
tality for patients receiving hydrocortisone vs. placebo,
and therefore determined that there is no utility in treat-
ing patients with septic shock with steroids. Of note, the
CORTICUS trial excluded all patients who had been
administered long term steroids in the past 6 months or
short term steroids in the last four weeks prior to enroll-
ment while the prior study by Annane et al. did not ex-
clude these patients. Another interesting comparison
between these trials is that the CORTICUS trial enrolled
patients within 72 hours of onset of shock, while the
Annane et al. enrolled patients within three hours of
onset of shock, raising concerns that these patients may
be at varying stages within their disease processes and re-
suscitation. In 2010, investigators from the CORTICUS
group published an additional analysis addressing the
ability of hydrocortisone to protect against organ dys-
function in severe sepsis patients. Moreno et al. found
that administration of hydrocortisone for 11 days vs. pla-
cebo resulted in improved performance on the SOFA
score. [50] They found that hydrocortisone-treated
patients had statistically significant improvement of car-
diovascular dysfunction from day 0 to day 7 vs. those
treated with placebo.
Packed red blood cell transfusion (PRBC) has been
recommended for the anemic severely septic patient
with inadequate oxygen delivery. The parameters often
employed for transfusion are an ScvO2< 70% with a
hematocrit< 30%; however, there is significant
skepticism that this intervention will truly affect the out-
comes of patients with severe sepsis. Fuller et al. found
that transfusion did not result in arrival at target ScvO2
of> 70%, nor did it result in less end organ dysfunction.
Patients in this study were retrospectively analyzed, with
one group receiving PRBC transfusion and the other
undergoing resuscitation with purely crystalloid. [51]
Further investigation is necessary to determine what role
PRBC transfusion will have in sepsis resuscitation strat-
egies, as PRBC transfusion has been associated with
acute lung injury, infection, and increased mortality.
Resuscitation: antimicrobial utilization
Appropriate antimicrobial administration and early, ad-
equate source control are mainstays in the treatment of
the septic ED patient. The importance of early anti-
microbial therapy in patients with septic shock was
brought to the forefront by Kumar et al. in 2006. Kumar
and his colleagues completed a retrospective cohort
study of 2,731 adult patients with septic shock, examin-
ing mortality in patients who received antimicrobials
after the onset of recurrent or persistent hypotension.
[5] They found that administration of an appropriate
antimicrobial within one hour of identified hypotension
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administration of antimicrobial resulted in a 7.6% de-
crease in survival.
Similarly, Gaieski et al. found overall mortality
decreased by 13.7% in a cohort of 261 patients receiving
uniform, algorithmic hemodynamic resuscitation when
appropriate antibiotics were administered in less than
one hour from triage time (33.2% vs. 19.5%; OR 0.3; 95%
CI 0.11 to 0.83; p = 0.02). [52] Puskarich and colleagues
further investigated this concept in post-hoc analysis of
the LACTATES trial. [53] Researchers analyzed time
from triage to first dose of antibiotics vs. time from
shock recognition to first dose of antibiotics, and com-
pared these data to in-hospital mortality. They found
that 59% of patients received antibiotics after shock rec-
ognition and had an odds ratio of in-hospital mortality
of 2.35 when compared with patients who had received
antibiotics prior to shock recognition. This study also
shows no increase in mortality associated with the delay
in antibiotics over the first three hours after shock rec-
ognition. Of note is that Puskarich and colleagues did
not analyze the “appropriateness” of antibiotic choice,
and primarily looked at the first dose of antibiotics
given, which may explain some difference in the two
papers’ findings. Also, the overall mortality of patients in
the LACTATES trial was significantly lower than that inTable 2 Common Causes of Severe Sepsis by Organ System*
Organ Etiology Diagnost
Lungs Pneumonia Chest rad
-Hospital acquired CT scan o
-Community acquired
Abdomen Appendicitis Abdomin
Cholecystitis/Cholangitis CT scan o
Bowel perforation Right upp
Peritonitis HIDA sca





Bones Osteomyelitis Bone scan
Sinusitis CT scan o
Central Nervous System Meningitis/Encephalitis Lumbar p
Spinal abscess MRI of th
CT scan o
Blood Secondary from other source Blood cul
Catheter associated *Remove
Unknown *Approximately 20% of patients will have an
*Adapted from Levy et al. The Surviving Sepsis Campaign: results of an internationa
Crit. Care Med. 2010;38(2):367–374.Gaieski et al’s investigation. In summary, all of these
papers endorse early antimicrobials as a component of a
comprehensive resuscitation protocol, with data to sup-
port the use of appropriate antimicrobial choice in
addition to administration prior to shock recognition.
The combination of an antimicrobial algorithm coupled
with an aggressive resuscitative protocol has resulted in
improved outcomes for patients with severe sepsis and
septic shock.
Care bundles
With significant advancement in the care of the septic
patient and implementation of guidelines for bundled
care, investigators involved in the Surviving Sepsis Cam-
paign demonstrated a decline in 28 day mortality from
37% to 30.8% over two years. [13] Compliance with the
initial six hour bundle, termed the resuscitation bundle,
increased from 10.9% to 31.3% of subjects over the two
years after initiation of the SSC guidelines. It is difficult
to interpret if the improved outcomes that were
observed should be attributed to the SSC Guidelines, or
to a heightened appreciation by emergency medicine
and critical care practitioners that time sensitive care of
sepsis begins in the ED.
In their study published in 2007, the Finnsepsis study
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any instrumentation ie. Indwelling foley catheter
and culture
or MRI
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l guideline-based performance improvement program targeting severe sepsis.
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linary ICUs in Finland. They found that compliance with
sepsis management bundle guidelines in patients with
severe sepsis was poor. In fact, no female patient (whose
tidal volumes per predicted body weight could be calcu-
lated) was ventilated with a tidal volume of less than
6 ml/kg. Despite this, ICU and hospital mortality rates
(15.5% and 28.3%, respectively) were lower than in many
other published studies. [54] The most important pre-
dictor of survival was administration of antimicrobials
within three hours of presentation.
With the refinement of diverse methodologies for
identifying and treating patients with severe sepsis or
septic shock at the most proximal point of entry into the
healthcare system, resuscitation is beginning earlier and
patient outcomes seem to be improving. Bundled care of
the septic patient prompts providers to employ end-
points of resuscitation and emphasizes time-sensitive
critical interventions such as early antimicrobial admin-
istration and aggressive volume resuscitation in the
golden hours of sepsis prior to the development of
multi-organ compromise. More research is necessary to
confirm that use of bundles indeed directly leads to
improved outcomes.
Conclusion
In summary, severe sepsis and septic shock are medical
emergencies that affect hundreds of thousands of indivi-
duals annually and result in death in about one third of
these patients. Severe sepsis and septic shock are disease
processes that require aggressive, time sensitive inter-
ventions, which has lead to the adoption of the practice
of early-goal directed therapy and other aspects of
bundled sepsis care in emergency departments inter-
nationally (Table 2). Since the inception of this concept
of early aggressive management of the septic patient,
many advances have occurred to help further the care of
these patients. Advances in methods for hemodynamic
monitoring, the use of appropriate antimicrobial therapy,
more sophisticated understanding of the risks and bene-
fits of aggressively controlling glucose levels, choice of
vasopressor therapy, and the utility of steroid implemen-
tation in the septic patient have lead to significant im-
provement in patient care. Despite controversy with
regard to implementation and utilization of the Surviv-
ing Sepsis Campaign recommendations, emergency
departments that have been compliant with the guide-
lines have seen significant improvement in their out-
comes and more survivors. In summary, severe sepsis is
a time critical disease, and therefore, one of significant
concern to the emergency medicine physician.
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